Kolek planning to go pro
Russia set to approve Covid vaccine, even though the study is still in the midst of phase 2 studies. Frightening…https://thehill.com/policy/international/509496-russia-aiming-to-approve-covid-19-vaccine-within-weeks-reportRussia’s vaccine still needs to finish its second phase of testing, which officials say they expect to complete by Aug. 3. Then, the third phase of testing will be conducted at the same time that front-line health care workers are vaccinated, according to the network.——————-The Russians are calling this a “Sputnik moment,“ but it also has the very real potential to be more like Chernobyl.
China has already been vaccinating their military too. Too bad we can't see transparent results on what happen in each of these experiments.
Here is a follow up to my post about med profs saying that we should not necessarily be concerned about falling antibody counts. This is written by a virologist at Yale who has been putting out a lot of very interesting studies on covid. It’s an opinion piece but I found also very informative to a layperson like me. https://www.nytimes.com/2020/07/31/opinion/coronavirus-antibodies-immunity.html
Estimates of only 43% to 66%, not 90%, needed to be vaccinated to protect the unvaccinated.
AP poll shows that only 42% will get vaccine when made available. If the vaccines is (optimistically) 60-70% effective, that is nowhere near enough for herd immunity. Vaccines do not cure viruses. Vaccinations do
One thing I will look for is whether or not Fauci endorses it. If we get word salad from him I would wait
Getting charged $10,984 for an $8 antibody test...https://twitter.com/propublica/status/1302185399121588224?s=19
I see there is a story that Aztra Zeneca is putting their Phase 3 vaccine trial on hold to study a patient who had adverse reaction.
Yep, and this is of the most promising vaccines. No detail so far on what the reaction was, but it sounds like the participant will survive. Hopefully they quickly determine that it was unrelated to the vaccine, so they can resume without too much delay.This is why they need to fully complete and analyze the phase 3 trials before the FDA approves anything. They did not see this type of reaction in the phase 1 or phase 2 trials, and a phase 3 trial is often the first time officials learn of a significant reaction to an investigational drug.https://www.usatoday.com/story/news/health/2020/09/08/report-covid-vaccine-candidate-created-oxford-university-and-astrazeneca-put-hold/5752569002/
Also a good example of why the phase 3 trials can take a long time. An adverse reaction, a death, and everything gets shut down until they can be 100% certain it was not related to the drug/vaccine.
https://www.pittwire.pitt.edu/news/pitt-scientists-discover-tiny-antibody-component-highly-effective-preventing-and-treating-sarsPitt has been sciencing their asses off since the beginning of this. It sure would be helpful if this is shown to be effective in humans.
NIH closely evaluating the adverse event in the Astra Zeneca trial...but A-Z is not being very forthcoming. Glad to see NIH is pressing them on this serious event, and disappointed that A-Z is being so evasive. I hope NIH keeps the pressure on, and only gives the green light if and when satisfactory answers are provided.NIH is ‘very concerned’ about serious side effect in coronavirus vaccine trialhttps://www.latimes.com/science/story/2020-09-15/nih-concerned-side-effect-in-astrazeneca-coronavirus-vaccine-trial“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, a division of the NIH. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.”A great deal of uncertainty remains about what happened to the unnamed patient. AstraZeneca said the trial volunteer recovered from a severe inflammation of the spinal cord and is no longer hospitalized.Nath and another neurologist said they understood that the patient was afflicted with transverse myelitis, though the company has not confirmed this. Transverse myelitis produces symptoms involving inflammation along the spinal cord that can cause pain, muscle weakness and paralysis.AstraZeneca “need to be more forthcoming with a potential complication of a vaccine which will eventually be given to millions of people,” Nath said. “We would like to see how we can help, but the lack of information makes it difficult to do so.”